Archive for Closing

Title Alliance Ltd. Announces Appointment of Closing Managers, Julia Argamin and Jacqueline Hernandez, and Processor, Aylen Montenegro, for Global Title Alliance in Miami


Media, PA (PRWEB) May 13, 2015

Title Alliance, a RESPA-compliant ESOP company that specializes in joint ventured title insurance agencies for the residential real estate industry announced that their Global Title Alliance operation has appointed closing managers and a processor. Julia Argamin and Jacqueline Hernandez have been appointed closing managers and Aylen Montenegro has been appointed Processor. The Global Title Alliance operation was announced earlier this week and is part of Title Alliance’s continued expansion efforts in Florida.

Argamin’s experience in the real estate industry dates back to 2002. Since then, she has handled all facets of the title process from pre closing through settlement and post-closing. Most recently, Argamin managed a branch location for another title operation. Her experience allows her the expertise required to review title commitments, lien searches, estoppels, payoffs, surveys and to clear title requirements. She is a licensed title agent fluent in English, Spanish and Portuguese and looks forward to servicing the agents of Keller Williams and their clients.

“It’s very exciting for me to continue doing what I love by managing a title branch knowing that our company has the back-end support and systems provided by Title Alliance.” She continues, “With the industry on the brink of change, I’m certain that Global Alliance will remain in a very strong position due to the emphasis on education and compliance by Title Alliance.”

Hernandez’s experience in the real estate industry dates back to 1995. As a paralegal, her duties included processing new title requests, obtaining title search and examining title, curing title defects, preparing title commitments and obtaining requirements show in the title commitment and insuring that the title is cleared for closing. She also coordinates closing dates with all parties, conducts closings, ensures files are balanced, prepares closing packages for post closing, and has experience in international clientele and corporate structure. Hernandez is a licensed title agent fluent in English and Spanish.

“Taking the step next in my career as a branch manager is something that I always wanted to do when the fit was right,” says Hernandez. “Global Title Alliance’s Miami Beach Branch is the perfect location for me to grow personally and professionally. I am confident in both my abilities and am thrilled to have the support of Title Alliance and their family of companies as my resource.”

Montengero’s background consists of a blend of lending, real estate and title work dating back to 2003. Her focus is on customer service and satisfaction and her commitment to getting the job done efficiently and on time is something her customers value. Montengero has experience ordering all necessary documents on a property in order to close in timely manners. She also has specialized in post-closing files, including but not limited to, disbursing checks and reconciling escrow accounts. Montegenro is also fluent in English and Spanish.

“The team that we have in place in our Global Title Alliance operation is one to watch,” says Nancy D. Warner, Director for Title Alliance. “Their skillsets complement one another and their commitment to being on the forefront of the changes in the industry aligns well with our values and focus. We are excited to watch them grow personally and professionally in their roles and know that this operation will achieve many milestones.”

Global Title Alliance has two locations:

Miami Branch:

700 N.E. 90th Street

Miami, FL 33138

Miami Beach Branch

1680 Meridian Avenue

Miami Beach, FL 33139

Orders can be placed online at http://www.globaltitlealliance.com/order

The staff is focused on training and learning the new systems, procedures and tools all while servicing their clients with the highest level of professionalism and precision.

About Title Alliance:

Title Alliance, Ltd, an ESOP Company is located in Media, PA and has been creating RESPA compliant title joint ventures since 1983 with lenders, mortgage bankers, realtors, builders and credit unions. Their roots date back to 1948 when their first agency, which is still in existence today, was formed. For more information or to find out how a Title Alliance’s partnership or title management skills could benefit you visit them online or contact Lindsay Smith at 800-220-3901 x 165.







More Fitness Press Releases

Peak Commercial Announces Successful Closing on Multifamily Units in Inglewood Area as Part of a 1031 Exchange Transaction


Woodland Hills, CA (PRWEB) March 10, 2015

“The Inglewood / LAX corridor is proving itself a new opportunity for commercial real estate investors,” states Kevin M. Levine, EVP of Peak Commercial (http://www.peakcommercial.com) referring to his recent transaction involving two multifamily assets in close proximity to LAX and Hollywood Park. Peak Commercial specializes in commercial buyer / seller representation in multifamily, retail, office building, industrial, land and REO commercial transactions. Levine notes increased interest from investors looking for new opportunities for expansion. The current sale, in Levine’s opinion “represents even more commercial real estate deals to be had in the Southwest Los Angeles sector.”

“The combination of available commercial inventory, Los Angeles Metro service expansion into the area, and renewed interest in building an NFL stadium on the site of the Hollywood Park Racetrack facility has drawn investors back to Southwest Los Angeles and has had a significant impact of commercial property values,” according to Levine. The multi-property deal includes adjacent multi-family units located at 10202-10206 S.10th Avenue near LAX, and a 12-unit complex on 921 N. Cedar Avenue closer to Hollywood Park with an average price per unit estimated at $ 140,000.

Peak Commercial represented the investor for the multifamily properties, facilitating the acquisition as part of a 1031 Exchange. The guidelines of a 1031 Exchange allow investors the ability to sell a property involved in a business transaction and reinvest the proceeds in a similar property to defer capital gain taxes. “Working with our buyer, we crafted a deal that not only included the acquisition of income property with amazing potential, but also maximized returns over the long term by mitigating tax liability.”

Peak Commercial is one of the entities in the Peak Corporate Network, headquartered in Woodland Hills, California. In addition to commercial real estate brokerage services, the Peak Corporate Network group of companies provide loss mitigation and workout services, residential real estate brokerage services, escrow services, 1031 exchange services, real estate financing, short sale services, foreclosure services and loan servicing. For more information, visit http://www.peakcorp.com.

The Peak Corporate Network is a brand that represents a group of related separate legal entities, each providing its unique set of real estate services.







Find More Workout Press Releases

AxoGen, Inc. Announces Closing of Public Offering of Common Stock


Alachua, FL (PRWEB) February 10, 2015

AxoGen, Inc. (NASDAQ: AXGN), a leading medical technology company with a unique and innovative portfolio of products used to repair injured peripheral nerves, today announced the closing of its previously announced underwritten public offering of 4,728,000 shares of its common stock at a price to the public of $ 2.75 per share resulting in gross proceeds to AxoGen from the offering of approximately $ 13.0 million, before deducting underwriting discounts and commissions and other estimated offering expenses payable by AxoGen. In addition, the Company announced that the underwriter fully exercised its over-allotment option for the purchase of an additional 709,200 shares, which will result in additional gross proceeds of approximately $ 2.0 million. The closing of the over-allotment option is expected to be completed on or about February 13, 2015, subject to customary closing conditions. Wedbush PacGrow Life Sciences has acted as sole manager for the offering.

AxoGen intends to use the net proceeds of the offering for continued expansion of its sales force, surgeon education program and general corporate purposes.

The shares described above were offered by AxoGen pursuant to a shelf registration statement on Form S-3 previously filed with the Securities and Exchange Commission (the “SEC”), which the SEC declared effective on May 9, 2014. A prospectus supplement and accompanying prospectus relating to the offering has been filed with the SEC and is available on the SEC’s website located at http://www.sec.gov. Electronic Copies of the prospectus supplement and the accompanying prospectus may also be obtained from the offices of Wedbush Securities Inc., Two Embarcadero Center, Suite 600, San Francisco, CA 94111, Attn: ECM Prospectus Department, by calling 415.274.6819, or by email at Vinnie.Devone(at)wedbush(dot)com.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy these shares, nor shall there be any sale of these shares in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.

About AxoGen, Inc.

AxoGen (NASDAQ: AXGN) is a leading medical technology company dedicated to peripheral nerve repair. AxoGen’s portfolio of regenerative medicine products is available in the United States, Canada and several European countries and includes Avance® Nerve Graft, which AxoGen believes is the only off-the-shelf commercially available processed nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site, AxoGuard® Nerve Connector, a porcine submucosa extracellular matrix (“ECM”) coaptation aid for tensionless repair of severed nerves, and AxoGuard® Nerve Protector, a porcine submucosa ECM product used to wrap and protect injured peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments.

Avance® Nerve Graft is processed in the United States by AxoGen. AxoGuard® Nerve Connector and AxoGuard® Nerve Protector are manufactured in the United States by Cook Biotech Incorporated, and are distributed exclusively by AxoGen. AxoGen maintains its corporate offices in Alachua, Florida and is the parent of its wholly owned operating subsidiary, AxoGen Corporation.

To learn more about AxoGen, visit our website at http://www.AxoGenInc.com.

Cautionary Statement Concerning Forward-Looking Statements

This Press Release contains “forward-looking” statements as defined in the Private Securities Litigation Reform Act of 1995, including statements about the closing of the over-allotment option and the AxoGen’s proposed use of proceeds. These statements are based on management’s current expectations or predictions of future conditions, events or results based on various assumptions and management’s estimates of trends and economic factors in the markets in which we are active, as well as our business plans. Words such as “expects”, “anticipates”, “intends”, “plans”, “believes”, “seeks”, “estimates”, “projects”, “forecasts”, “continue”, “may”, “should”, variations of such words and similar expressions are intended to identify such forward-looking statements. The forward-looking statements may include, without limitation, statements regarding our growth, our product development, product potential, or the intended use of proceeds from the offering. The forward-looking statements are subject to risks and uncertainties, which may cause results to differ materially from those set forth in the statements. Forward-looking statements in this release should be evaluated together with the many uncertainties that affect AxoGen’s business and its market, particularly those discussed in the risk factors and cautionary statements in AxoGen’s filings with the Securities and Exchange Commission. Forward-looking statements are not guarantees of future performance, and actual results may differ materially from those projected. The forward-looking statements are representative only as of the date they are made, and, except as required by law, AxoGen assumes no responsibility to update any forward-looking statements, whether as a result of new information, future events or otherwise.







More Exercise Program Press Releases